Current pharmacotherapy for Alzheimer's disease
A Lleo, SM Greenberg, JH Growdon - Annu. Rev. Med., 2006 - annualreviews.org
Alzheimer's disease (AD) is an age-related neurodegenerative disease that affects
approximately 4.5 million people in the United States. The mainstays of current …
approximately 4.5 million people in the United States. The mainstays of current …
Current pharmacotherapy for Alzheimer's disease
A Lleó, SM Greenberg… - Annual review of …, 2006 - pubmed.ncbi.nlm.nih.gov
Alzheimer's disease (AD) is an age-related neurodegenerative disease that affects
approximately 4.5 million people in the United States. The mainstays of current …
approximately 4.5 million people in the United States. The mainstays of current …
Current Pharmacotherapy for Alzheimer's Disease
A Lleó, SM Greenberg, JH Growdon - Annual Review of Medicine, 2006 - cir.nii.ac.jp
抄録< jats: p> Alzheimer's disease (AD) is an age-related neurodegenerative disease that
affects approximately 4.5 million people in the United States. The mainstays of current …
affects approximately 4.5 million people in the United States. The mainstays of current …
Current pharmacotherapy for Alzheimer's disease.
A Lleó, SM Greenberg, JH Growdon - Annual Review of Medicine, 2006 - europepmc.org
Alzheimer's disease (AD) is an age-related neurodegenerative disease that affects
approximately 4.5 million people in the United States. The mainstays of current …
approximately 4.5 million people in the United States. The mainstays of current …